Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis
CompletedPhase 3NCT00658736
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is a triple-blind, parallel group, randomized controlled trial to assess the benefit of triamcinolone injection as a therapeutic measure for control of chronic pancreatitis pain. The treatment group will undergo EUS-CPB with bupivicaine plus triamcinolone ("therapeutic block"). There control group will undergo EUS-CPB with bupivicaine alone ("diagnostic block").
Study details
- Official title
- A Randomized, Triple-Blinded Study of Endoscopic Ultrasound Guided Celiac Plexus Blockade (EUS-CPB) With Bupivicaine and Triamcinolone vs. Bupivicaine Alone for the Treatment of Pain in Chronic Pancreatitis
- Conditions
- Interventions
- Drug: Triamcinolone
- Drug: Bupivicaine alone
- Sponsor
- The Cleveland Clinic
- Collaborators
- American Society for Gastrointestinal Endoscopy; TAP Pharmaceutical Products Inc.
- Start date
- 2008-03
- Primary completion
- 2011-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion criteria include: * Age \>18 yrs * Ability for informed consent * Chronic pancreatic-type abdominal pain (type B) (11). Exclusion criteria include: * Pregnancy * Malignancy * Recent acute pancreatitis (within 2 months) * Elevated INR (\>1.5) or low platelet count (\<75 cells/mm3) * Allergy to eggs or "caine" anesthetics or corticosteroids; AND * Becks depression score\>20.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00658736